Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) EPS (Weighted Average and Diluted) (2019 - 2025)

Historic EPS (Weighted Average and Diluted) for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $0.87.

  • Harmony Biosciences Holdings' EPS (Weighted Average and Diluted) rose 1012.66% to $0.87 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.18, marking a year-over-year increase of 5071.09%. This contributed to the annual value of $2.03 for FY2024, which is 468.1% down from last year.
  • According to the latest figures from Q3 2025, Harmony Biosciences Holdings' EPS (Weighted Average and Diluted) is $0.87, which was up 1012.66% from $0.68 recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' EPS (Weighted Average and Diluted) ranged from a high of $1.44 in Q3 2022 and a low of -$0.17 during Q3 2021
  • In the last 5 years, Harmony Biosciences Holdings' EPS (Weighted Average and Diluted) had a median value of $0.48 in 2023 and averaged $0.53.
  • As far as peak fluctuations go, Harmony Biosciences Holdings' EPS (Weighted Average and Diluted) plummeted by 7724.55% in 2021, and later skyrocketed by 94705.88% in 2022.
  • Quarter analysis of 5 years shows Harmony Biosciences Holdings' EPS (Weighted Average and Diluted) stood at $0.38 in 2021, then surged by 107.89% to $0.79 in 2022, then crashed by 43.04% to $0.45 in 2023, then decreased by 17.54% to $0.37 in 2024, then skyrocketed by 134.44% to $0.87 in 2025.
  • Its EPS (Weighted Average and Diluted) was $0.87 in Q3 2025, compared to $0.68 in Q2 2025 and $0.78 in Q1 2025.